Hosted on MSN9mon
Lilly's weight-loss drug Zepbound found to treat sleep apnea
After being approved for chronic weight management at the end of 2023, Zepbound can be prescribed to overweight patients with at least one co-morbid condition, such as obstructive sleep apnea or ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) mechanisms to tackle the root causes of obesity. It ...
Hosted on MSN9mon
Lilly’s weight-loss drug reduces sleep apnea severity in late-stage trials
Zepbound, which was approved for chronic weight management late last year, can be prescribed to overweight patients with at least one co-morbid condition such as obstructive sleep apnea or ...
Benefits Pro14d
State becomes first to add Wegovy-like drugs to essential health benefits package
On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...